Advanced Pharma Inc.
Summary
- Total Recalls
- 99 (5 Class I)
- 510(k) Clearances
- 0
- Inspections
- 2
- Compliance Actions
- 0
Known Names
advanced pharmaceutical technology, advanced pharma
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1251-2019 | Class II | HYDROmorphone 20 mg/100 mL Injectable Solution, Hydromorphone HCl 20 mg 0.9% Sodium Chloride 100 mL, | April 26, 2019 |
| D-1021-2019 | Class II | Glycopyrrolate Injectable Solution 1 mg/5 mL (0.2 mg per mL), Sterile single use syringe, NDC: 42852 | March 13, 2019 |
| D-1020-2019 | Class II | Phenylephrine HCl, 500 mcg in 0.9% Sodium Chloride, QS 5 mL Injectable Solution 500 mcg/5 mL (100 mc | March 13, 2019 |
| D-1022-2019 | Class II | Phenylephrine HCl, 400 mcg in 0.9% Sodium Chloride, QS 10 mL Injectable Solution 400 mcg/10 mL (40 m | March 13, 2019 |
| D-1033-2019 | Class II | Morphine Sulfate 30 mg/30 mL (1 mg/mL) Injectable Solution Morphine Sulfate 30 mg 0.9% Sodium Chlori | March 13, 2019 |
| D-1023-2019 | Class II | Phenylephrine HCl, 1 mg in 0.9% Sodium Chloride, QS 10 mL Injectable Solution 1 mg/10 mL (100 mcg pe | March 13, 2019 |
| D-1034-2019 | Class II | Phenylephrine HCl, 1,200 mcg in 0.9% Sodium Chloride, QS 10 mL Injectable Solution 1,200 mcg/10 mL ( | March 13, 2019 |
| D-1030-2019 | Class II | Heparin 10 Units/10 mL 10 Units in 0.45% Sodium Chloride, QS 10 mL, Injectable Solution, Dwell, 10mL | March 13, 2019 |
| D-1029-2019 | Class II | Esmolol HCl Injectable Solution 100 mg/10 mL (10 mg per mL)10mL Sterile single use syringe, NDC: 428 | March 13, 2019 |
| D-1016-2019 | Class II | HYDROmorphone HCl 1 mg in 0.9% Sodium Chloride, QS 5 mL Injectable Solution 1 mg/5 mL (0.2 mg per mL | March 13, 2019 |
| D-1025-2019 | Class II | Glycopyrrolate 0.6 mg/3 mL (0.2 mg per mL) Injectable Solution, 3 mL Sterile single use syringe, For | March 13, 2019 |
| D-1032-2019 | Class II | Phenylephrine HCl, 1 mg in Sterile Water for Injection, QS 10 mL Injectable Solution 1 mg/10 mL (100 | March 13, 2019 |
| D-1027-2019 | Class II | 2% Lidocaine HCl Injectable Solution, 100 mg/5 mL (20 mg per mL), 5mL Sterile single use syringe, ND | March 13, 2019 |
| D-1024-2019 | Class II | Neostigmine Methylsulfate Injection Solution 5 mg/5mL (1 mg per mL), 5mL Sterile single use syringe, | March 13, 2019 |
| D-1031-2019 | Class II | Heparin 5,000 Units/5mL (1,000 Units per mL) Injectable Solution, 5,000 Units in 0.9% Sodium Chlorid | March 13, 2019 |
| D-1018-2019 | Class II | fentaNYL 2500 mcg/250 mL Injectable Solution, Fentanyl 0.9% Sodium Chloride, QS, Sterile single use | March 13, 2019 |
| D-1028-2019 | Class II | Phenylephrine HCl, 800 mcg in 0.9% Sodium Chloride, QS 10 mL Injectable Solution, 800 mcg/10 mL (80 | March 13, 2019 |
| D-1019-2019 | Class II | Midazolam Benzodiazepine 50 mg/50 mL (1 mg/mL) Injectable Solution, Midazolam HCl 0.9% Sodium Chlori | March 13, 2019 |
| D-1017-2019 | Class II | fentaNYL 1000 mcg/100 mL Injectable Solution Fentanyl 0.9% Sodium Chloride, QS, 100 mL, Sterile sing | March 13, 2019 |
| D-1026-2019 | Class II | 2% Lidocaine HCl Injectable Solution, 60 mg/3 mL (20 mg per mL), 3mL Sterile single use syringe, NDC | March 13, 2019 |